ATC Group: R03BA01 Beclometasone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03BA01 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03B Other drugs for obstructive airway diseases, inhalants
4 R03BA Glucocorticoids
5 R03BA01 Beclometasone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
RESPIR Respiratory (Inhalation) 0.8 mg (aerosol)
RESPIR Respiratory (Inhalation) 0.8 mg (powder)
RESPIR Respiratory (Inhalation) 1.5 mg (solution)

Active ingredients in R03BA01

Active Ingredient

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.

Related product monographs

Document Type Information Source  
 BECLATE Nasal spray MPI, Generic Health Products Regulatory Authority (ZA)
 BECLAZONE 100mg Pressurised inhalation, solution MPI, EU: SmPC Υπουργείο Υγείας (CY)
 BECLAZONE 250mg Pressurised inhalation, solution MPI, EU: SmPC Υπουργείο Υγείας (CY)
 BECOTIDE EVOHALER Pressurised inhalation, solution MPI, EU: SmPC Health Products Regulatory Authority (IE)
 CLENIL FORTE SPRAY Pressurised inhalation solution MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CLENIL Pressurised inhalation solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 QVAR MDI Pressurised inhalation, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SOPROBEC Pressurised inhalation solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

United States medicines

Medicines classified under this ATC code globally

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.